These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter. Blackshear JL; Stambler BS; Strauss WE; Roy D; Dias VC; Beach CL; Ebener MK Am J Cardiol; 1996 Dec; 78(11):1246-50. PubMed ID: 8960583 [TBL] [Abstract][Full Text] [Related]
25. Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study. Rehnqvist N Ann Clin Res; 1981; 13 Suppl 30():68-72. PubMed ID: 7027895 [TBL] [Abstract][Full Text] [Related]
26. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Mooss AN; Wurdeman RL; Mohiuddin SM; Reyes AP; Sugimoto JT; Scott W; Hilleman DE; Seyedroudbari A Am Heart J; 2000 Jul; 140(1):176-80. PubMed ID: 10874282 [TBL] [Abstract][Full Text] [Related]
28. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group. Salerno DM; Dias VC; Kleiger RE; Tschida VH; Sung RJ; Sami M; Giorgi LV Am J Cardiol; 1989 May; 63(15):1046-51. PubMed ID: 2650517 [TBL] [Abstract][Full Text] [Related]
30. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. Ko WJ; Chu SH J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of ibutilide for termination of atrial fibrillation and flutter. Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275 [TBL] [Abstract][Full Text] [Related]
33. Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol. Coumel P; Escoubet B; Attuel P Am Heart J; 1984 Oct; 108(4 Pt 2):1098-108. PubMed ID: 6148870 [TBL] [Abstract][Full Text] [Related]
34. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent. Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group. Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645 [TBL] [Abstract][Full Text] [Related]
36. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Barbier GH; Shettigar UR; Appunn DO Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691 [TBL] [Abstract][Full Text] [Related]
37. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial. Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T; J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682 [TBL] [Abstract][Full Text] [Related]
38. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection. Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486 [TBL] [Abstract][Full Text] [Related]
39. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy of propafenone in supraventricular arrhythmias]. Kauffmann R; Goich J; Parra C; Ayala A; Manzur F Rev Med Chil; 1989 Apr; 117(4):401-5. PubMed ID: 2519393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]